Aline Silva Santos Sena

Aline Silva Santos Sena

Auto-generated profile, based on publicly available information

Aline Silva Santos Sena

Faculdade de Ciências Médicas de Campina Grande, Campina Grande, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
MLMaria Do Carmo Pinto Lima
Maria Do Carmo Pinto Lima
AMAdriana Suely Oliveira Melo
Adriana Suely Oliveira Melo
ASAline Silva Santos Sena
Aline Silva Santos Sena
VBVivianne de Oliveira Barros
Vivianne de Oliveira Barros
MAMelania Maria Ramos Amorim
Melania Maria Ramos Amorim
SUMMARY OBJECTIVE Evaluate the prevalence of metabolic syndrome (MS) and the main associated maternal factors in women without pre-gestational conditions, in early pregnancy and in the immediate postpartum. METHODS Two hundred pregnant women were evaluated at the 16th week of pregnancy, and 187 were reassessed postpartum. MS was diagnosed according to the criteria by the National Cholesterol Education Program Adult Treatment Panel III. In addition to the diagnostic criteria, anthropometric measures, blood pressure, metabolic profile, and visceral and subcutaneous fat thickness (by ultrasonography) were collected from the pregnant woman. The student’s t-test was used to compare the prevalence of MS and its components in the 16th week and in the postpartum. Multiple logistic regression was performed to identify the principal factors associated with the syndrome. RESULTS The prevalence of the MS was 3.0% in early pregnancy and 9.7% postpartum (p=0.01). Following multiple logistic regression, the prepregnancy body mass index (BMI) (p=0.04) and high-density lipoprotein cholesterol (HDL-c) (p=0.02) remained associated with MS at 16 weeks, and triglyceride levels evaluated in postpartum (p<0.001) with MS in postpartum. CONCLUSION The frequency of the MS was high in the immediate postpartum. The factors associated were prepregnancy BMI and HDL-c at the 16th week, as well as triglyceride levels postpartum.

31 October 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
RNRAQUEL Vieira NIELLA
RAQUEL Vieira NIELLA
ASAline Silva Sena
Aline Silva Sena
JCJanaina Maria Xavier Corrêa
Janaina Maria Xavier Corrêa
PSPriscila Carvalho Lima Rocha Soares
Priscila Carvalho Lima Rocha Soares
TPTaísa Miranda Pinto
Taísa Miranda Pinto
MLMário Sérgio Lima de DE LAVOR
Mário Sérgio Lima de DE LAVOR
This study aimed to evaluate the preemptive analgesic effect of amantadine on postoperative pain control in female dogs that underwent ovariohysterectomy. Twenty female dog were randomly assigned to two groups of ten. The control group (CONTROL) received oral placebo capsules, while the amantadine (AMANT) group received 5 mg/kg of oral amantadine one hour before sedation. All the animals were premedicated with 3 mg/kg (IM) meperidine, induced with propofol and maintained with isofluorane. The transanesthetic physiological parameters were recorded, and postoperative pain was evaluated every hour after extubation for six hours with the Dynamic Interactive Visual Analog Scale (DIVAS) and mechanical nociceptive threshold (MNT) and when the necessary analgesic rescue was administered (morphine, 0.2 mg/kg (IM)). During the surgical procedure, there was no significant difference in the variables measured between the two groups. Regarding postoperative pain assessment, there was a significant difference in the DIVAS score (p = 0.004) between the groups, in which AMANT required fewer rescues than did CONTROL (p = 0.03). The MNT was significantly higher ​​in AMANT than in CONTROL (p = 0.03). The results suggested that the preoperative administration of amantadine decreased analgesic requirement in female dogs that underwent elective ovariohysterectomy.

1 May 2015 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
AMAdriana Melo
Adriana Melo
MAMelania Maria Ramos Amorim
Melania Maria Ramos Amorim
MBMaira Creusa Farias Belo
Maira Creusa Farias Belo
MPMaria Do Carmo Pinto
Maria Do Carmo Pinto
ASAline Silva Santos Sena
Aline Silva Santos Sena
FMFelipe Dias Martins
Felipe Dias Martins

6 January 2022
Verified
Book Chapter
Open access
RFRaquel Sonalle Abreu Franco
Raquel Sonalle Abreu Franco
ASAline Silva Santos Sena
Aline Silva Santos Sena

10 February 2019 in Jornal de Pediatria
Verified
Journal Article
Open access
ASAline Silva Santos Sena
Aline Silva Santos Sena
Alex Sandro Rolland SouzaAlex Sandro Rolland Souza
Alex Sandro Rolland Souza
VBVivianne de Oliveira Barros
Vivianne de Oliveira Barros
MLMaria Do Carmo Pinto Lima
Maria Do Carmo Pinto Lima
AMAdriana Suely Oliveira Melo
Adriana Suely Oliveira Melo
MAMelania Maria Ramos de Amorim
Melania Maria Ramos de Amorim
Objective: To assess fetal visceral adiposity and associated factors during pregnancy. Methods: Secondary analysis of prospective cohort data with 172 pairs (pregnant woman/fetus) treated at public health units. Anthropometric data, metabolic (glucose, glycated hemoglobin, insulin, insulin resistance, total cholesterol and fractions, triglycerides) measures, fetal biometry, and visceral and subcutaneous adiposity in the binomial (pregnant woman/fetus) were evaluated at the 16th, 28th and 36th gestational weeks by ultrasonography. Pearson's correlation coefficient and multiple linear regression were used, with a significance level of 5%. Results: At the 16th week, the mean age of the pregnant women was 26.6 +/- 5.8 years and mean weight was 62.7 +/- 11.5 kg; 47.0% had normal weight, 28.3% were overweight, 13.3% were underweight, and 11.2% were obese. At 36 weeks, 44.1% had inadequate gestational weight gain, 32.5% had adequate gestational weight gain, and 23.3% had excessive gestational weight gain. Fetal visceral adiposity at week 36 showed a positive correlation with maternal variables: weight (r= 0.15) and body mass index (r= 0.21) at the 16th; with weight (r= 0.19), body mass index (r= 0.24), and gestational weight gain (r= 0.21) at the 28th; and with weight (r= 0.22), body mass index (r= 0.26), and gestational weight gain (r= 0.21) at the 36th week. After multiple linear regression, adiposity at the 28th week remained associated with fetal variables: abdominal circumference (p < 0.0001), head circumference (p = 0.01), area (p< 0.0001), and thigh circumference (p< 0.001). At the 36th week, adiposity remained associated with the abdominal circumference of the 28th (p= 0.02) and 36th weeks (p <0.001). Conclusion: Adiposity was positively correlated with the measurements of the pregnant woman. After the multivariate analysis, the persistence of the association occurred with the abdominal circumference, a central adiposity measurement with a higher metabolic risk. (C) 2019 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.

28 May 2020 in Jornal de Pediatria (Versão em Português)
Verified
Journal Article
Open access
PDF file
ASAline Silva Santos Sena
Aline Silva Santos Sena
Alex Sandro Rolland SouzaAlex Sandro Rolland Souza
Alex Sandro Rolland Souza
VBVivianne de Oliveira Barros
Vivianne de Oliveira Barros
MLMaria Do Carmo Pinto Lima
Maria Do Carmo Pinto Lima
AMAdriana Suely Oliveira Melo
Adriana Suely Oliveira Melo
MAMelania Maria Ramos de Amorim
Melania Maria Ramos de Amorim
To assess fetal visceral adiposity and associated factors during pregnancy. Secondary analysis of prospective cohort data with 172 pairs (pregnant woman/fetus) treated at public health units. Anthropometric data, metabolic (glucose, glycated hemoglobin, insulin, insulin resistance, total cholesterol and fractions, triglycerides) measures, fetal biometry, and visceral and subcutaneous adiposity in the binomial (pregnant woman/fetus) were evaluated at the 16th, 28th and 36th gestational weeks by ultrasonography. Pearson's correlation coefficient and multiple linear regression were used, with a significance level of 5%. At the 16th week, the mean age of the pregnant women was 26.6 ± 5.8 years and mean weight was 62.7 ± 11.5 kg; 47.0% had normal weight, 28.3% were overweight, 13.3% were underweight, and 11.2% were obese. At 36 weeks, 44.1% had inadequate gestational weight gain, 32.5% had adequate gestational weight gain, and 23.3% had excessive gestational weight gain. Fetal visceral adiposity at week 36 showed a positive correlation with maternal variables: weight (r = 0.15) and body mass index (r = 0.21) at the 16th; with weight (r = 0.19), body mass index (r = 0.24), and gestational weight gain (r = 0.21) at the 28th; and with weight (r = 0.22), body mass index (r = 0.26), and gestational weight gain (r = 0.21) at the 36th week. After multiple linear regression, adiposity at the 28th week remained associated with fetal variables: abdominal circumference (p < 0.0001), head circumference (p = 0.01), area (p < 0.0001), and thigh circumference (p < 0.001). At the 36th week, adiposity remained associated with the abdominal circumference of the 28th (p = 0.02) and 36th weeks (p < 0.001). Adiposity was positively correlated with the measurements of the pregnant woman. After the multivariate analysis, the persistence of the association occurred with the abdominal circumference, a central adiposity measurement with a higher metabolic risk. Avaliar a adiposidade visceral fetal e fatores associados na gestação. Análise secundária de dados de coorte prospectiva com 172 pares (gestantes/fetos) atendidas em unidades públicas de saúde. Foram avaliadas nas gestantes na 16a, 28a e 36a semana gestacional: medidas antropométricas, metabólicas (glicose, hemoglobina glicada, insulina, resistência à insulina, colesterol total e frações, triglicerídeos), biometria fetal e adiposidade visceral e subcutânea no binômio (gestantes/feto) por ultrassonografia. Utilizamos o coeficiente de correlação de Pearson e regressão linear múltipla, com nível de significância de 5%. Na 16ª semana a média de idade das gestantes foi de 26,6 ± 5,8 anos e peso 62,7 ± 11,5 quilogramas, 47,0% eram eutróficas, 28,3% sobrepeso, 13,3% baixo peso e 11,2% obesas. Na 36a semana, 44,1% tiveram ganho ponderal gestacional insuficiente, 32,5% adequado e 23,3% excessivo. A adiposidade visceral fetal na 36a semana apresentou correlação positiva com variáveis maternas: peso (r = 0,15) e índice de massa corpórea (r = 0,21) na 16a; com peso (r = 0,19), índice de massa corpórea (r = 0,24) e ganho ponderal gestacional (r = 0,21) na 28a; com peso (r = 0,22), índice de massa corpórea (r = 0,26) e ganho ponderal gestacional (r = 0,21) na 36a semana. Após regressão linear múltipla a adiposidade na 28a semana permaneceu associada com variáveis fetais: circunferência abdominal (p < 0,0001), circunferência cefálica (p = 0,01), área (p < 0,0001) e circunferência da coxa (p < 0,001). Na 36a semana com circunferência abdominal da 28a (p = 0,02) e 36a semana (p < 0,001). A adiposidade foi positivamente correlacionada com medidas da gestante, após análise multivariada a persistência da associação deu‐se com a circunferência abdominal, medida de adiposidade central, de maior risco metabólico.